Pharma Icebreaker: Partnering & Innovation in Autoimmunity: Targets, Modalities & Next Generation Biologics

Time: 8:10 am
day: Day One

Details:

  • Exploring pharma’s evolving strategy across known targets, new modalities, and combination therapies to shape future partnering discussions
  • Evaluating autoimmune cell therapy and next generation biologics to understand their capacity to drive future investments
  • Uncovering key competitive differentiators prioritised in search and evaluation processes to drive deal-making and partnership decisions

Speakers:

Hussein Al-Mossawi Dr. Hussein Al-Mossawi, Vice President of Immunology Research at Immunocore, leads the development of T cell receptor-based immunotherapies for autoimmune and inflammatory diseases. A clinician Read more
Saifur Rahman Dr. Saifur Rahman is Director of Search & Evaluation, Immunology Partnering at Sanofi, where he leads efforts to identify and assess external innovation in immunology. Read more
Carolyn Tyler
Nicola La Monica Nicola La Monica is Senior Director of Strategic Search and Evaluation at Johnson & Johnson, where he identifies and advances external innovation in immunology and Read more
Jonathan Zombeck Dr. Jonathan Zombeck is Director of Business Development at Visterra Inc., an Otsuka company, with nearly two decades of experience spanning neuroscience research, technology licensing, Read more
Nikhil Mutyal Nikhil is currently Head of Search and Evaluation for Respiratory and Immunology (R&I) at AstraZeneca in this role he is responsible for deal making in Read more